Europe Veterinary Vaccine Market, By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines); By Animal Type (Livestock (Poultry, Aqua, Ruminants, Swine), Companion (Canine, Feline)); By Route of Admi

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,599	200 Pages	BlueWeave Consulting	August, 2023	BLWC18285261

Best Price Guarantee
Price	from $3,599
Length	200 Pages
Publisher	BlueWeave Consulting
Published Date	August, 2023
SKU	BLWC18285261

Europe Veterinary Vaccine Market, By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines); By Animal Type (Livestock (Poultry, Aqua, Ruminants, Swine), Companion (Canine, Feline)); By Route of Administration (Subcutaneous, Intramuscular, Intranasal); By Country (Germany, United Kingdom, Italy, France, Spain, Belgium, Russia, Netherlands, Rest of Europe), Competitive Landscape & Forecast, 2019–2029

Europe Veterinary Vaccine Market Size Set to Reach USD 4.5 Billion by 2029

Europe veterinary vaccine market is flourishing due to increasing pet ownership, rising awareness about animal health, a growing demand for livestock products, and government initiatives to control and prevent animal diseases.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Europe veterinary vaccine market size at USD 3,208.92 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the Europe veterinary vaccine market size to grow at a CAGR of 5.71% reaching a value of USD 4,477.33 million by 2029. The European veterinary vaccination industry is expanding rapidly. Increasing awareness about animal health and illness prevention is driving the demand for vaccines. Vaccine manufacturers are always developing to create more effective and safer vaccines. Government actions and laws are helping to expand the market by encouraging vaccine research and development. A burgeoning pet population and the need to protect animals from disease are driving the market. Vaccination programs are being implemented in veterinary clinics and animal husbandry establishments. Overall, the Europe veterinary vaccine industry has a bright future, with consistent breakthroughs in animal healthcare and illness prevention.

Europe Veterinary Vaccine Market – Overview

Veterinary vaccines are essential tools in safeguarding the health and well-being of animals. These vaccines are specifically designed to prevent or reduce the incidence of various infectious diseases in animals, ranging from livestock, such as cattle, pigs, and poultry, to domestic pets like dogs and cats. By stimulating the animal's immune system, vaccines create a protective response against harmful pathogens, such as viruses and bacteria, thereby preventing disease transmission. Regular vaccination not only promotes animal welfare but also contributes to public health by reducing zoonotic disease risks. Veterinary vaccines play a pivotal role in maintaining the health of animal populations and supporting sustainable agricultural practices.

Impact of COVID-19 on Europe Veterinary Vaccine Market

The COVID-19 pandemic significantly impacted the Europe veterinary vaccine market, driving accelerated growth. As lockdowns were imposed, people spent more time at home, resulting in increased pet adoption rates and heightened awareness of animal health. Veterinarians reported a surge in demand for vaccines to protect companion animals. With disruptions in food supply chains, farmers sought to safeguard livestock health, leading to a rise in demand for livestock vaccines. The pandemic also prompted governments and private sector investment in vaccine research and development. These factors combined to propel the Europe veterinary vaccine market to new heights amid the crisis.

Europe Veterinary Vaccine Market – By Animal Type

By animal type, Europe veterinary vaccine market is split into Livestock and Companion segments. The livestock segment is further divided into Poultry, Aqua, Ruminants, and Swine subsegments. The companion segment is also sub-segmented into Canine and Feline. The livestock segment represents the vaccination needs for various farm animals, contributing significantly to the overall market. The companion segment, on the other hand, includes Canine and Feline sub-segments, catering to vaccination requirements for domestic pets. However, it is the livestock segment that holds a larger share, reflecting the importance of safeguarding and maintaining the health of livestock animals in the European veterinary vaccine market.

Competitive Landscape

Europe veterinary vaccine market is fiercely competitive. Major companies in the market include Zoetis, Ceva Santé Animale, Merck & Co., Inc., Vetoquinol S.A., Boehringer Ingelheim Gmbh, Elanco, Virbac, Heska, and Dechra Pharmaceuticals Plc. These companies use various strategies, including increasing investments in their R&D activities, mergers and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in Europe veterinary vaccine market.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Europe Veterinary Vaccine Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Europe Veterinary Vaccine Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

1. Research Framework: 1.1. Research Objective; 1.2. Product Overview; 1.3. Market Segmentation
2. Executive Summary
3. Europe Veterinary Vaccine Market Insights: 3.1. Industry Value Chain Analysis; 3.2. DROC Analysis; 3.2.1. Growth Drivers; 3.2.1.1. Increasing pet ownership; 3.2.1.2. Growing livestock production; 3.2.2. Restraints; 3.2.2.1. High research and development costs; 3.2.3. Opportunities; 3.2.3.1. Rising prevalence of zoonotic diseases; 3.2.4. Challenges; 3.2.4.1. Stringent regulatory requirements; 3.3. Technological Advancements/Recent Developments; 3.4. Regulatory Framework; 3.5. Porter’s Five Forces Analysis; 3.5.1. Bargaining Power of Suppliers; 3.5.2. Bargaining Power of Buyers; 3.5.3. Threat of New Entrants; 3.5.4. Threat of Substitutes; 3.5.5. Intensity of Rivalry
4. Europe Veterinary Vaccine Market Overview: 4.1. Market Product & Forecast, 2019–2029; 4.1.1. By Value (USD Million); 4.2. Market Share & Forecast; 4.2.1. By Product; 4.2.1.1. Attenuated Live Vaccines; 4.2.1.2. Inactivated Vaccines; 4.2.1.3. Subunit Vaccines; 4.2.1.4. DNA Vaccines; 4.2.1.5. Recombinant Vaccines; 4.2.2. By Animal Type; 4.2.2.1. Livestock; 4.2.2.1.1. Poultry; 4.2.2.1.2. Aqua; 4.2.2.1.3. Ruminants; 4.2.2.1.4. Swine; 4.2.2.2. Companion; 4.2.2.2.1. Canine; 4.2.2.2.2. Feline; 4.2.2.2.3. Others; 4.2.3. By Route of Administration; 4.2.3.1. Subcutaneous; 4.2.3.2. Intramuscular; 4.2.3.3. Intranasal; 4.2.4. By Country; 4.2.4.1. Germany; 4.2.4.2. United Kingdom; 4.2.4.3. Italy; 4.2.4.4. France; 4.2.4.5. Spain; 4.2.4.6. Belgium; 4.2.4.7. Russia; 4.2.4.8. The Netherlands; 4.2.4.9. Rest of Europe
5. Germany Veterinary Vaccine Market: 5.1. Market Product & Forecast, 2019–2029; 5.1.1. By Value (USD Million); 5.2. Market Share & Forecast; 5.2.1. By Product; 5.2.2. By Animal Type; 5.2.3. By Route of Administration
6. United Kingdom Veterinary Vaccine Market: 6.1. Market Product & Forecast, 2019–2029; 6.1.1. By Value (USD Million); 6.2. Market Share & Forecast; 6.2.1. By Product; 6.2.2. By Animal Type; 6.2.3. By Route of Administration
7. Italy Veterinary Vaccine Market: 7.1. Market Product & Forecast, 2019–2029; 7.1.1. By Value (USD Million); 7.2. Market Share & Forecast; 7.2.1. By Product; 7.2.2. By Animal Type; 7.2.3. By Route of Administration
8. France Veterinary Vaccine Market: 8.1. Market Product & Forecast, 2019–2029; 8.1.1. By Value (USD Million); 8.2. Market Share & Forecast; 8.2.1. By Product; 8.2.2. By Animal Type; 8.2.3. By Route of Administration
9. Spain Veterinary Vaccine Market: 9.1. Market Product & Forecast, 2019–2029; 9.1.1. By Value (USD Million); 9.2. Market Share & Forecast; 9.2.1. By Product; 9.2.2. By Animal Type; 9.2.3. By Route of Administration
10. Belgium Veterinary Vaccine Market: 10.1. Market Product & Forecast, 2019–2029; 10.1.1. By Value (USD Million); 10.2. Market Share & Forecast; 10.2.1. By Product; 10.2.2. By Animal Type; 10.2.3. By Route of Administration
11. Russia Veterinary Vaccine Market: 11.1. Market Product & Forecast, 2019–2029; 11.1.1. By Value (USD Million); 11.2. Market Share & Forecast; 11.2.1. By Product; 11.2.2. By Animal Type; 11.2.3. By Route of Administration
12. Netherlands Veterinary Vaccine Market: 12.1. Market Product & Forecast, 2019–2029; 12.1.1. By Value (USD Million); 12.2. Market Share & Forecast; 12.2.1. By Product; 12.2.2. By Animal Type; 12.2.3. By Route of Administration
13. Rest of Europe Veterinary Vaccine Market: 13.1. Market Product & Forecast, 2019–2029; 13.1.1. By Value (USD Million); 13.2. Market Share & Forecast; 13.2.1. By Product; 13.2.2. By Animal Type; 13.2.3. By Route of Administration
14. Competitive Landscape: 14.1. List of Key Players and Their Offerings; 14.2. Europe Veterinary Vaccine Company Market Share Analysis, 2022; 14.3. Competitive Benchmarking, By Operating Parameters; 14.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
15. Impact of Covid-19 on Europe Veterinary Vaccine Market
16. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis): 16.1. Zoetis; 16.2. Ceva Santé Animale; 16.3. Merck & Co., Inc.; 16.4. Vetoquinol S.A.; 16.5. Boehringer Ingelheim Gmbh; 16.6. Elanco; 16.7. Virbac; 16.8. Heska; 16.9. Dechra Pharmaceuticals Plc; 16.10. Other Prominent Players
17. Key Strategic Recommendations
18. Research Methodology: 18.1. Qualitative Research; 18.1.1. Primary & Secondary Research; 18.2. Quantitative Research; 18.3. Market Breakdown & Data Triangulation; 18.3.1. Secondary Research; 18.3.2. Primary Research; 18.4. Breakdown of Primary Research Respondents, By Region; 18.5. Assumptions & Limitations; *Financial information of non-listed companies can be provided as per availability.; **The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable
List of Figures: Figure 1 Europe Veterinary Vaccine Segmentation; Figure 2 Europe Veterinary Vaccine Market Value Chain Analysis; Figure 3 Company Market Share Analysis, 2022; Figure 4 Europe Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029; Figure 5 Europe Veterinary Vaccine Market Share, By Product, By Value, 2019–2029; Figure 6 Europe Veterinary Vaccine Market Share, By Animal Type, By Value, 2019–2029; Figure 7 Europe Veterinary Vaccine Market Share, By Route of Administration, By Value, 2019–2029; Figure 8 Europe Veterinary Vaccine Market Share, By Country, By Value, 2019–2029; Figure 9 Germany Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029; Figure 10 Germany Veterinary Vaccine Market Share, By Product, By Value, 2019–2029; Figure 11 Germany Veterinary Vaccine Market Share, By Animal Type, By Value, 2019–2029; Figure 12 Germany Veterinary Vaccine Market Share, By Route of Administration, By Value, 2019–2029; Figure 13 United Kingdom Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029; Figure 14 United Kingdom Veterinary Vaccine Market Share, By Product, By Value, 2019–2029; Figure 15 United Kingdom Veterinary Vaccine Market Share, By Animal Type, By Value, 2019–2029; Figure 16 United Kingdom Veterinary Vaccine Market Share, By Route of Administration, By Value, 2019–2029; Figure 17 Italy Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029; Figure 18 Italy Veterinary Vaccine Market Share, By Product, By Value, 2019–2029; Figure 19 Italy Veterinary Vaccine Market Share, By Animal Type, By Value, 2019–2029; Figure 20 Italy Veterinary Vaccine Market Share, By Route of Administration, By Value, 2019–2029; Figure 21 France Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029; Figure 22 France Veterinary Vaccine Market Share, By Product, By Value, 2019–2029; Figure 23 France Veterinary Vaccine Market Share, By Animal Type, By Value, 2019–2029; Figure 24 France Veterinary Vaccine Market Share, By Route of Administration, By Value, 2019–2029; Figure 25 Spain Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029; Figure 26 Spain Veterinary Vaccine Market Share, By Product, By Value, 2019–2029; Figure 27 Spain Veterinary Vaccine Market Share, By Animal Type, By Value, 2019–2029; Figure 28 Spain Veterinary Vaccine Market Share, By Route of Administration, By Value, 2019–2029; Figure 29 Belgium Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029; Figure 30 Belgium Veterinary Vaccine Market Share, By Product, By Value, 2019–2029; Figure 31 Belgium Veterinary Vaccine Market Share, By Animal Type, By Value, 2019–2029; Figure 32 Belgium Veterinary Vaccine Market Share, By Route of Administration, By Value, 2019–2029; Figure 33 Russia Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029; Figure 34 Russia Veterinary Vaccine Market Share, By Product, By Value, 2019–2029; Figure 35 Russia Veterinary Vaccine Market Share, By Animal Type, By Value, 2019–2029; Figure 36 Russia Veterinary Vaccine Market Share, By Route of Administration, By Value, 2019–2029; Figure 37 Netherlands Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029; Figure 38 Netherlands Veterinary Vaccine Market Share, By Product, By Value, 2019–2029; Figure 39 Netherlands Veterinary Vaccine Market Share, By Animal Type, By Value, 2019–2029; Figure 40 Netherlands Veterinary Vaccine Market Share, By Route of Administration, By Value, 2019–2029; Figure 41 Rest of Europe Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029; Figure 42 Rest of Europe Veterinary Vaccine Market Share, By Product, By Value, 2019–2029; Figure 43 Rest of Europe Veterinary Vaccine Market Share, By Animal Type, By Value, 2019–2029; Figure 44 Rest of Europe Veterinary Vaccine Market Share, By Route of Administration, By Value, 2019–2029
List of Tables: Table 1 Europe Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029; Table 2 Europe Veterinary Vaccine Market Size, By Product, By Value, 2019–2029; Table 3 Europe Veterinary Vaccine Market Size, By Animal Type, By Value, 2019–2029; Table 4 Europe Veterinary Vaccine Market Size, By Route of Administration, By Value, 2019–2029; Table 5 Europe Veterinary Vaccine Market Size, By Country, By Value, 2019–2029; Table 6 Germany Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029; Table 7 Germany Veterinary Vaccine Market Size, By Product, By Value, 2019–2029; Table 8 Germany Veterinary Vaccine Market Size, By Animal Type, By Value, 2019–2029; Table 9 Germany Veterinary Vaccine Market Size, By Route of Administration, By Value, 2019–2029; Table 10 United Kingdom Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029; Table 11 United Kingdom Veterinary Vaccine Market Size, By Product, By Value, 2019–2029; Table 12 United Kingdom Veterinary Vaccine Market Size, By Animal Type, By Value, 2019–2029; Table 13 United Kingdom Veterinary Vaccine Market Size, By Route of Administration, By Value, 2019–2029; Table 14 Italy Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029; Table 15 Italy Veterinary Vaccine Market Size, By Product, By Value, 2019–2029; Table 16 Italy Veterinary Vaccine Market Size, By Animal Type, By Value, 2019–2029; Table 17 Italy Veterinary Vaccine Market Size, By Route of Administration, By Value, 2019–2029; Table 18 France Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029; Table 19 France Veterinary Vaccine Market Size, By Product, By Value, 2019–2029; Table 20 France Veterinary Vaccine Market Size, By Animal Type, By Value, 2019–2029; Table 21 France Veterinary Vaccine Market Size, By Route of Administration, By Value, 2019–2029; Table 22 Spain Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029; Table 23 Spain Veterinary Vaccine Market Size, By Product, By Value, 2019–2029; Table 24 Spain Veterinary Vaccine Market Size, By Animal Type, By Value, 2019–2029; Table 25 Spain Veterinary Vaccine Market Size, By Route of Administration, By Value, 2019–2029; Table 26 Belgium Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029; Table 27 Belgium Veterinary Vaccine Market Size, By Product, By Value, 2019–2029; Table 28 Belgium Veterinary Vaccine Market Size, By Animal Type, By Value, 2019–2029; Table 29 Belgium Veterinary Vaccine Market Size, By Route of Administration, By Value, 2019–2029; Table 30 Russia Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029; Table 31 Russia Veterinary Vaccine Market Size, By Product, By Value, 2019–2029; Table 32 Russia Veterinary Vaccine Market Size, By Animal Type, By Value, 2019–2029; Table 33 Russia Veterinary Vaccine Market Size, By Route of Administration, By Value, 2019–2029; Table 34 Netherlands Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029; Table 35 Netherlands Veterinary Vaccine Market Size, By Product, By Value, 2019–2029; Table 36 Netherlands Veterinary Vaccine Market Size, By Animal Type, By Value, 2019–2029; Table 37 Netherlands Veterinary Vaccine Market Size, By Route of Administration, By Value, 2019–2029; Table 38 Rest of Europe Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029; Table 39 Rest of Europe Veterinary Vaccine Market Size, By Product, By Value, 2019–2029; Table 40 Rest of Europe Veterinary Vaccine Market Size, By Animal Type, By Value, 2019–2029; Table 41 Rest of Europe Veterinary Vaccine Market Size, By Route of Administration, By Value, 2019–2029; Table 42 Zoetis Company Overview; Table 43 Zoetis Financial Overview; Table 44 Ceva Santé Animale Company Overview; Table 45 Ceva Santé Animale Financial Overview; Table 46 Merck & Co., Inc. Company Overview; Table 47 Merck & Co., Inc. Financial Overview; Table 48 Vetoquinol S.A. Company Overview; Table 49 Vetoquinol S.A. Financial Overview; Table 50 Boehringer Ingelheim Gmbh Company Overview; Table 51 Boehringer Ingelheim Gmbh Financial Overview; Table 52 Elanco Company Overview; Table 53 Elanco Financial Overview; Table 54 Virbac Company Overview; Table 55 Virbac Financial Overview; Table 56 Heska Company Overview; Table 57 Heska Financial Overview; Table 58 Dechra Pharmaceuticals Plc Company Overview; Table 59 Dechra Pharmaceuticals Plc Financial Overview